Literature DB >> 20429741

Good pregnancy outcome despite intrahepatic cholestasis.

Kaisa Turunen1, Markku Sumanen, Riitta-Liisa Haukilahti, Pertti Kirkinen, Kari Mattila.   

Abstract

OBJECTIVE: Pregnant women complaining of itching are screened for intrahepatic cholestasis (ICP) by laboratory tests in primary healthcare. Cases of ICP are referred to specialist care. In Finland, ICP occurs in 1% of pregnancies. The aim was to study the outcome of deliveries. Design. Retrospective study of ICP pregnancies. Data were collected from the hospital discharge register, patient records, and the labour register.
SETTING: The region of Tampere University Hospital in Finland.
SUBJECTS: Altogether 687 ICP cases from 1969 to 1988 and two controls for each. Main outcome measures. ICP patients were compared with controls in terms of mother's age, pregnancy multiplicity, weeks of gestation at delivery, frequency of induction and Caesarean section, length of ward period, child's weight, Apgar scores, and stillbirth.
RESULTS: For ICP patients, the risk for hospital stay of 10 days or more was eightfold (OR 8.41), for gestational weeks less than 37 at delivery sevenfold (OR 7.02), for induction threefold (OR 3.26), for baby's low weight at birth almost twofold (OR 1.86), and for Caesarean section one and a half fold (OR 1.47). The possibility of the incidence of multiple pregnancy was two and a half fold (OR 2.49, 95%). ICP was not associated with mother's age, the baby's risk of stillbirth, or low Apgar scores.
CONCLUSION: ICP mothers are found and taken care of appropriately, and thus ICP is only a minor risk for mothers and their children.

Entities:  

Mesh:

Year:  2010        PMID: 20429741      PMCID: PMC3442314          DOI: 10.3109/02813431003784001

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  23 in total

Review 1.  Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management.

Authors:  F Lammert; H U Marschall; A Glantz; S Matern
Journal:  J Hepatol       Date:  2000-12       Impact factor: 25.083

2.  The GP's role in maternity care.

Authors:  Johann A Sigurdsson
Journal:  Scand J Prim Health Care       Date:  2003-06       Impact factor: 2.581

3.  Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy.

Authors:  T Laatikainen; A Tulenheimo
Journal:  Int J Gynaecol Obstet       Date:  1984-04       Impact factor: 3.561

Review 4.  Intrahepatic cholestasis of pregnancy: an intriguing pregnancy-specific disorder.

Authors:  Alfredo M Germain; Jorge A Carvajal; Juan Carlos Glasinovic; Sumie Kato C; Catherine Williamson
Journal:  J Soc Gynecol Investig       Date:  2002 Jan-Feb

5.  The quality of electronic patient records in Finnish primary healthcare needs to be improved.

Authors:  Suvi Vainiomäki; Maisa Kuusela; Paula Vainiomäki; Päivi Rautava
Journal:  Scand J Prim Health Care       Date:  2008       Impact factor: 2.581

6.  Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study.

Authors:  Anne Ropponen; Reijo Sund; Seija Riikonen; Olavi Ylikorkala; Kristiina Aittomäki
Journal:  Hepatology       Date:  2006-04       Impact factor: 17.425

7.  Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates.

Authors:  Anna Glantz; Hanns-Ulrich Marschall; Lars-Ake Mattsson
Journal:  Hepatology       Date:  2004-08       Impact factor: 17.425

8.  Cholestasis of pregnancy. Clinical and laboratory studies.

Authors:  B Berg; G Helm; L Petersohn; N Tryding
Journal:  Acta Obstet Gynecol Scand       Date:  1986       Impact factor: 3.636

9.  Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy.

Authors:  M Savander; A Ropponen; K Avela; N Weerasekera; B Cormand; M-L Hirvioja; S Riikonen; O Ylikorkala; A-E Lehesjoki; C Williamson; K Aittomäki
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

10.  Bile acids increase response and expression of human myometrial oxytocin receptor.

Authors:  Alfredo M Germain; Sumie Kato; Jorge A Carvajal; Guillermo J Valenzuela; Gloria L Valdes; Juan C Glasinovic
Journal:  Am J Obstet Gynecol       Date:  2003-08       Impact factor: 8.661

View more
  6 in total

Review 1.  Review of a challenging clinical issue: Intrahepatic cholestasis of pregnancy.

Authors:  Sebiha Ozkan; Yasin Ceylan; Orhan Veli Ozkan; Sule Yildirim
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

2.  Intrahepatic cholestasis of pregnancy: biochemical predictors of adverse perinatal outcomes.

Authors:  Hui Chen; Yuan Zhou; Dong-Rui Deng; Hai-Yan Hao; Jing Dang; Jing Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-06-17

3.  ACG Clinical Guideline: Liver Disease and Pregnancy.

Authors:  Tram T Tran; Joseph Ahn; Nancy S Reau
Journal:  Am J Gastroenterol       Date:  2016-02-02       Impact factor: 10.864

4.  Intrahepatic cholestasis of pregnancy and associated causes of death: a cohort study with follow-up of 27-46 years.

Authors:  Suvi-Tuulia Hämäläinen; Kaisa Turunen; Kari J Mattila; Markku Sumanen
Journal:  BMC Womens Health       Date:  2018-06-19       Impact factor: 2.809

Review 5.  Stillbirth and associated perinatal outcomes in obstetric cholestasis: a systematic review and meta-analysis of observational studies.

Authors:  Manoj Mohan; Antoniou Antonios; Justin Konje; Stephen Lindow; Mohamed Ahmed Syed; Anthony Akobeng
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-05-02

Review 6.  Dermatological Diseases Associated with Pregnancy: Pemphigoid Gestationis, Polymorphic Eruption of Pregnancy, Intrahepatic Cholestasis of Pregnancy, and Atopic Eruption of Pregnancy.

Authors:  Christine Sävervall; Freja Lærke Sand; Simon Francis Thomsen
Journal:  Dermatol Res Pract       Date:  2015-11-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.